Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors

By afschroeder • October 16, 2025

Zhu L, Cheung YM, Chiang C, Gallagher EJ, Hamnvik OR, Mammen J, Quandt Z, Jones R, McDunn J, Al-Bahadili H, Angell T, Bancos I, Betof Warner A, Blackwell S, Calabrese C, Cho TA, Dougan M, Ferreira M, Funchain P, Herndon J, Johnson DB, Kennedy R, Kheterpal M, Khouri M, Lechner MG, Lim AM, Markova A, Meara A, Overton L, Perdigoto AL, Sachithanandan N, Sharon E, Spain L, Tsai K, Yarchoan M, Reynolds KL, Shariff A. Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors. J Immunother Cancer. 2025 Oct 15;13(10):e011865. doi: 10.1136/jitc-2025-011865. PMID: 41093625; PMCID: PMC12530408.

Tags: diabetes, Endocrinology, Hypophysitis, immune checkpoint inhibitor, Immune related adverse event - irAE, Publications, Thyroid toxicity

Related Posts

Incidence, Risk Factors, and Survival Implications of Immune-Related Adverse Events in Patients With Metastatic Breast Cancer

Baclig NV, Chengappa M, Soliman AJ, Jacob S, LeVee A, Fisch S, Face C, Chaudhry S, Idossa D, Poonacha T, Huppert L, Quintal L, Melisko[...]

Annexin A1 inhibits neuronal apoptosis in amyotrophic lateral sclerosis by restraining the Hippo pathway

Zhang Y, Dong X, Shai Y, Masood A, Han D, Hu Y, He Z, Zhou Z, Jiang H. Annexin A1 inhibits neuronal apoptosis in amyotrophic[...]

Nicotinamide Adenine Dinucleotide Augmentation in Diabetic Kidney Disease: Randomized Trial Study Protocol

Chandra MS, Gagliano-Jucá T, Shekhar S, Pencina KM, Travison TG, Garg R, McDonnell ME, Reid KF, Latham NK, Lam H, Meritus D, Yan Y, Isaza[...]